Your Republican Legislators: Defending the Rights of Poor Pharmaceutical Companies

Shares

It’s not surprising that none of the seven Republicans who voted in committee against a bill prohibiting drug companies from using prescription information for marketing purposes were available for quote in this piece by Mike Dennison.

House Bill 394 has a simple premise: drug companies are not entitled to use your prescription information for marketing purposes and that all Montanans have a right to privacy when it comes to the pharmaceuticals they are prescribed.

If I were a constituent of Pat Ingraham, Bill Beck, David Howard, Michael More,  Cary Smith, Ron Stoker, or Jeffrey Wellborn, I’d certainly be tempted to ask for an explanation of this vote.

If you appreciate our efforts to hold Montana Republicans accountable and the independent journalism here at The Montana Post, please consider supporting our work with a small pledge.

About the author

Don Pogreba

Don Pogreba is an eighteen-year teacher of English, former debate coach, and loyal, if often sad, fan of the San Diego Padres and Portland Timbers. He spends far too many hours of his life working at school and on his small business, Big Sky Debate.

His work has appeared in Politico and Rewire.

In the past few years, travel has become a priority, whether it's a road trip to some little town in Montana or a museum of culture in Ísafjörður, Iceland.

1
Leave a Reply

avatar
1 Comment threads
0 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
1 Comment authors
Glaucon Recent comment authors
  Subscribe  
Notify of
Glaucon
Member
Glaucon

Not that it is a reason to vote against HB394, but I wonder how much the pharmacies make by selling this information? I know a lot of the community pharmacy folks have tight bottom lines so I would just be curious if it is a significant source of income.

Do you know if MCPA testified on the bill?

Support Our Work!

Poll

What would be the most appropriate nickname for Matt Rosendale?

Follow Us on Twitter

Subscribe Via E-mail

0 /* ]]> */